mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.025 |
0.7 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.7 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.7 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |